# Hutchison China Meditech

> biopharmaceutical company

**Wikidata**: [Q10921659](https://www.wikidata.org/wiki/Q10921659)  
**Source**: https://4ort.xyz/entity/hutchison-china-meditech

## Summary
Hutchison China Meditech is a publicly traded biopharmaceutical company operating within the biomedicine industry and headquartered in Hong Kong. Founded in 2000, the firm operates as a subsidiary of the conglomerate Hutchison Whampoa and is dual-listed on international stock exchanges.

## Key Facts
*   **Official Name:** HUTCHISON CHINA MEDITECH LIMITED
*   **Alternative Official Name:** 和記中國醫藥科技有限公司
*   **Industry:** Biomedicine
*   **Description:** Biopharmaceutical company
*   **Legal Form:** Public company
*   **Inception:** 2000
*   **Headquarters:** Hong Kong
*   **Country:** Hong Kong
*   **Parent Organization:** Hutchison Whampoa
*   **Owner:** Hutchison Whampoa
*   **Stock Exchange Listings:** London Stock Exchange - AIM MTF (Ticker: HCM) and Nasdaq (Ticker: HCM)
*   **Website:** http://www.hutch-med.com/
*   **Google Knowledge Graph ID:** /g/11x7vkyl7
*   **VIAF ID:** 277327395
*   **Wikipedia Languages:** Chinese (zh)
*   **Sitelink Count:** 1

## FAQs
**What does Hutchison China Meditech do?**
Hutchison China Meditech is a biopharmaceutical company that operates within the broader biomedicine industry.

**Who owns Hutchison China Meditech?**
The company is owned by Hutchison Whampoa, which also serves as its parent organization.

**Where is Hutchison China Meditech located?**
The company's headquarters is located in Hong Kong.

**When was Hutchison China Meditech founded?**
The company was established in the year 2000.

**Where can I buy stock in Hutchison China Meditech?**
The company is traded on two major international exchanges: the London Stock Exchange's AIM MTF and the Nasdaq, both under the ticker symbol HCM.

## Why It Matters
As a publicly traded biopharmaceutical enterprise, Hutchison China Meditech represents a significant intersection of global finance and healthcare innovation. Operating under the umbrella of Hutchison Whampoa, the firm utilizes a public corporate structure to raise capital from global markets, supporting its biomedicine initiatives. The company plays a vital role in the sector by engaging in large-scale commercial operations while providing investment opportunities and market liquidity to public shareholders across both European and North American markets.

## Notable For
*   Being a prominent biopharmaceutical business headquartered in Hong Kong.
*   Operating as a public subsidiary of the major conglomerate Hutchison Whampoa.
*   Maintaining an international financial footprint with a dual listing on the London Stock Exchange and Nasdaq.
*   Trading under the unified ticker symbol "HCM" across its respective international markets.

## Body

### Corporate Identity and Naming
Hutchison China Meditech conducts its business officially under the name HUTCHISON CHINA MEDITECH LIMITED. In Chinese, the organization is formally known as 和記中國醫藥科技有限公司. The firm's public digital identity is anchored by its official website and an officially recognized logo. The logo file is hosted by Wikimedia Commons under the title "Chi-med_logo.png."

### Founding and Location
The enterprise was established in 2000. Its central operations and corporate base are situated in Hong Kong, which serves as both its official country of origin and the location of its physical headquarters.

### Corporate Structure and Ownership
Legally, the business operates as a public company. This status designates it as an enterprise that offers its securities to the general public, distributing ownership among public shareholders. The company is ultimately owned and governed by Hutchison Whampoa, which functions as its parent organization.

### Financial Market Presence
Reflecting its status as a public entity, Hutchison China Meditech is listed on two prominent international stock exchanges. It trades on the Nasdaq stock exchange as well as the London Stock Exchange's Alternative Investment Market (AIM MTF). Across both of these distinct markets, the company's equity is traded under the identical ticker symbol "HCM."

### Industry and Operations
The core focus of Hutchison China Meditech lies within the biomedicine sector. Its primary operational classification is that of a biopharmaceutical company, focusing its business activities on related medical research, development, and commercialization.

### Information and Authority Records
The company holds a Virtual International Authority File (VIAF) identifier of 277327395. It is also tracked within digital knowledge systems via its Google Knowledge Graph ID, which is /g/11x7vkyl7. In the context of open-source encyclopedias, the entity has a sitelink count of 1 and maintains a presence specifically on the Chinese language edition of Wikipedia.